Skip to main content

Table 1 Differences between heterotaxy and non-heterotaxy patients

From: Interstage mortality for functional single ventricle with heterotaxy syndrome: a retrospective study of the clinical experience of a single tertiary center

 

Heterotaxy (%)

Non-heterotaxy (%)

P value

N

39

71

 

Observation period (mo)

90.8 ± 93.9

107.7 ± 56.1

0.310

Male

25 (64.1)

35 (49.3)

0.163

Major associated anomaly

Pulmonary atresia

19 (48.7)

23 (32.4)

0.344

Anomalous pulmonary venous return

14 (35.9)

6 (8.5)

0.079

Age of 1st palliation (mo)

3.0 ± 3.1

2.9 ± 6.7

0.907

1st palliation

  

0.546

BT shunt

25 (64.1)

46 (64.8)

 

PAB

2 (5.1)

10 (14.1)

 

BCPS

12 (30.8)

15 (21.1)

 

Mortality

16 (41.0)

8 (11.3)

0.001

Median age of death (range) (mo)

4.4 (1.2-221.1)

9.4 (3.1-35.7)

0.427

Median time to death after palliation (range) (mo)

2.5 (0.6-62.2)

5.1 (1.7-32.3)

0.838

Causes of death

Infection

6 (37.5)

3 (37.5)

 

Sudden death

5 (31.3)

3 (37.5)

 

Arrhythmia

2 (12.5)

0

 

Pulmonary venous obstruction

2 (12.5)

1 (12.5)

 

Heart failure

1 (6.3)

1 (12.5)

 

Time of mortality

  

0.722

Before BCPS

13 (81.3)

6 (75.0)

 

After BCPS

3 (18.7)

2 (25.0)

 
  1. BT Blalock-Taussig, PAB pulmonary artery banding, BCPS bidirectional cavo-pulmonary shunt.